Hubungan Kadar Profil Lipid dengan Homosistein pada Pasien Dislipidemia di Laboratorium Klinik Prodia Tangerang

Authors

  • Intan Lambang Astrini Stikes Wira Medika Bali
  • Anak Agung Ayu Eka Cahyani Stikes Wira Medika Bali
  • Mardiyah Hayati Stikes Wira Medika Bali

DOI:

https://doi.org/10.57214/jka.v9i2.938

Keywords:

Dyslipidemia, HDL Cholesterol, Homocysteine, Lipid Profile, Triglycerides

Abstract

Dyslipidemia is one of the causes of coronary heart disease and stroke. Hypercholesterolemia can cause atherosclerosis. In recent years, there has been an independent risk factor that is an important factor in the presence of blood vessel wall abnormalities, namely homocysteine. Increased homocysteine has been shown to increase the risk of cardiovascular disease independently. This study is an observational analytical study using a cross-sectional design with a retrospective approach. The sample used was 33 respondents selected through a total sampling technique The results of the test on the relationship between Lipid Profile and homocysteine using statistical testing methods, namely Spearman's Rho, yielded the following results: there is no significant relationship between Total Cholesterol and homocysteine with a Sig value of 0.791 (>0.05) and a correlation coefficient of 0.048; there is no significant relationship between LDL Cholesterol and homocysteine with a Sig value of 0.272 (>0.05) and a correlation coefficient of -0.197; there is a significant relationship between HDL Cholesterol and homocysteine with a Sig value of 0.004 (<0.05) and a correlation coefficient of -0.487; there is a significant relationship between Triglycerides and Homocysteine with a Sig value of 0.047 (<0.05) and a correlation coefficient of 0.348. The conclusion of this study is that there is a significant relationship between HDL Cholesterol and Triglycerides to homocysteine in patients with Dyslipidemia at Prodia Clinical Laboratory Tangerang. Further research is needed with a larger sample size focusing on the gender and age of the respondents.

References

Adiputra, I. M. S., Trisnadewi, N. W., Oktaviani, N. P. W., & Munthe, S. A. (2021). Metodologi Penelitian Kesehatan.

Al-Omari, A. F., Aljawadi, Z. A. M., Omer, Z. K., & Al-Othman, A. K. (2021). Relation between Serum Homocysteine Level and Lipid Profile in Patients with Dyslipidemia. Biochemical and Cellular Archives, 21(1), 1147–1152.

Alkaissi, H., & McFarlane, S. I. (2023). Hyperhomocysteinemia and Accelerated Aging: The Pathogenic Role of Increased Homocysteine in Atherosclerosis, Osteoporosis, and Neurodegeneration. Cureus, 15(7), 1–16. https://doi.org/10.7759/cureus.42259

Alma Nazelia Syafni, R. Z. |. (2024). Penatalaksanaan Holistik Pada Wanita Usia 59 Tahun dengan Hipertensi dan Dislipidemia Melalui Pendekatan Kedokteran Keluarga di Wilayah Kerja Puskesmas Tanjung Sari. 14, 65–71.

Amaliah, R., Yaswir, R., & Prihandani, T. (2019). Gambaran Homosistein pada Pasien Infark Miokard Akut di RSUP Dr. M. Djamil Padang. Jurnal Kesehatan Andalas, 8(2), 351. https://doi.org/10.25077/jka.v8.i2.p351-355.2019

Azmi, A. S., Riandini, S., Effendi, R. E. R., & Utama, W. T. (2024). Penatalaksanaan Dislipidemia Pada Wanita Usia 60 Tahun Dengan. Jurnal Aisyiyah Medika, 9(1), 391– 408.

Bintang, A. K. (2023). Kadar Homosistein Plasma Berhubungan dengan Derajat Keparahan Stroke Iskemik Akut. Majalah Kedokteran Neurosains Perhimpunan Dokter Spesialis Saraf Indonesia, 39(3), 105–109. https://doi.org/10.52386/neurona.v39i3.237

Carnagarin, R., Nolde, J. M., Ward, N. C., Lugo-Gavidia, L. M., Chan, J., Robinson, S., Jose, A., Joyson, A., Azzam, O., Galindo Kiuchi, M., Mwipatayi, B. P., & Schlaich, M.

Castañer, O., Pintó, X., Subirana, I., Amor, A. J., Ros, E., Hernáez, Á., Martínez-González, M. Á., Corella, D., Salas-Salvadó, J., Estruch, R., Lapetra, J., Gómez-Gracia, E., Alonso-Gomez, A. M., Fiol, M., Serra-Majem, L., Corbella, E., Benaiges, D., Sorli, J. V., Ruiz-Canela, M., … Fitó, M. (2020). Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease. Journal of the American College of Cardiology, 76(23), 2712–2724. https://doi.org/10.1016/j.jacc.2020.10.008

Damanik, R. Z. (2023). Kadar Homosistein Sebagai Prediktor Derajat Keparahan Pasien Stroke Iskemik Fase Akut. 6(1), 358–364.

Faggiano, P., Ruscica, M., Bettari, S., Cherubini, A., Carugo, S., Corsini, A., Barbati, G., & Di Lenarda, A. (2023). LDL Cholesterol Variability Impacts the Prognosis of Patients with Chronic Ischemic Heart Disease: A Real-World Italian Experience. Journal of Clinical Medicine, 12(19). https://doi.org/10.3390/jcm12196231

Firdaus, M. 2021. Metodologi Penelitian Kuantitatif; Dilengkapi Analisis Regresi IBM SPSS Statistics Version 26.0. CV. DotPlus Publiser

Hartini, & Febiola, W. (2018). Hubungan Indeks Massa Tubuh (Imt) Terhadap Kadar Trigliserida Pada Wanita Usia 40-60 Tahun. Jurnal Sains Dan Teknologi Laboratorium Medik, 2(1), 2–7.https://doi.org/10.52071/jstlm.v2i1.13

Kemenkes RI. 2023. Dislipidemia. perpustakaan.kemkes.go.id

Kit insert ARCHITECT, 2015. Homocysteine Abbot Rev Nov 2015

Kit insert Roche, 2017. HDLC4 HDL-Cholesterol 4th generation Rev Mar 2017

Kit Insert Roche, 2017. TRIGL (Triglycerides) COBAS – COBAS C311/C501 Rev Nov 2017

Kit Insert Roche, 2019. LDL Cholesterol 3 rd Gen COBAS – COBAS C311/C501 Rev. Mei 2019

Kit Insert Roche, 2019. CHOL2 (Cholesterol Gen.2) OBAS–COBAS C311/C501 Rev Feb 2019

M. (2021). Comparison of lifestyle of catholics and seventh-day adventists and the relationship with homocysteine as risk factor for cardiovascular diseases, a cross- sectional study in polish males and females. International Journal of Environmental Research and Public Health, 18(1), 1–17. https://doi.org/10.3390/ijerph18010309

Majda, A., Zalewska-Puchała, J., Bodys-Cupak, I., Kamińska, A., Kurowska, A., & Suder,

Momin, M., Jia, J., Fan, F., Li, J., Dou, J., Chen, D., Huo, Y., & Zhang, Y. (2017). Relationship between plasma homocysteine level and lipid profiles in a community-based Chinese population. Lipids in Health and Disease, 16(1), 1–7. https://doi.org/10.1186/s12944-017-0441-6

P. (2021). Homocysteine predicts vascular target organ damage in hypertension and May serve as guidance for first-line antihypertensive therapy. Journal of Clinical Hypertension, 23(7), 1380–1389. https://doi.org/10.1111/jch.14265

Perkeni. (2021). Pengelolaan Dislipidemia Di Indonesia 2021. PB Perkeni, 1–2.

Shih, C. C., Shih, Y. L., & Chen, J. Y. (2021). The association between homocysteine levels and cardiovascular disease risk among middle-aged and elderly adults in Taiwan. BMC Cardiovascular Disorders, 21(1), 1–8. https://doi.org/10.1186/s12872-021-02000-x

Sm, V., Vyakarnam, S., & Bhongir, A. V. (2022). ORIGINAL RESEARCH A Study on Association of Serum Homocysteine and Lipid Profile in Patients with Type 2 Diabetes Mellitus. 2872–2880.

Maresa, A., Riski, M., & Ismed, S. (2023). Hubungan sikap dan keterpaparan informasi dengan pengetahuan remaja putri tentang kanker payudara. Jurnal ‘Aisyiyah Palembang, 8(1), 233–243.

Paganelli, F., Mottola, G., Fromonot, J., Marlinge, M., Deharo, P., Guieu, R., & Ruf, J. (2021). Hyperhomocysteinemia and cardiovascular disease: Is the adenosinergic system the missing link? International Journal of Molecular Sciences, 22(4), 1–20. https://doi.org/10.3390/ijms22041690

Rais, E. E., Aziz, I. R., & Surdianah, S. (2024). Pemeriksaan total kolesterol pada sampel serum darah dengan menggunakan metode fotometrik di Balai Besar Laboratorium Kesehatan Makassar. Filogeni: Jurnal Mahasiswa Biologi, 4(1), 19–27. https://doi.org/10.24252/filogeni.v4i1.42013

Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M. R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., Erdine, S., Halcox, J., Hobbs, R., Kjekshus, J., Filardi, P. P., Riccardi, G., Storey, R. F., & Wood, D. (2011). ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal, 32(14), 1769–1818. https://doi.org/10.1093/eurheartj/ehr158

Ruyani, A., & Nursa, E. (2024). Pengaruh Pemberian Ekstrak Buah E. Hemispahaerica. Hutan (Etlingera hemisphaerica Blume) Terhadap Pemulihan Hiperkolesterolemia Dan Hipertrigliseridemia Pada M. Musculus (Mus musculus). Jurnal Biosilampari: Jurnal Biologi, 6(2), 77–87.

Scudeler, T. L., da Costa, L. M. A., Nunes, R. A. B., Schneidewind, R. O., Brito, T. M., Pereira, D. C. G., de Oliveira, R. P., Santana, G. C., Castello, H., de Carvalho Cantarelli, M. J., & Junior, Á. A. (2024). Association between low-density lipoprotein cholesterol levels and all-cause mortality in patients with coronary artery disease: a real-world analysis using data from an international network. Scientific Reports, 14(1), 1–11. https://doi.org/10.1038/s41598-024-80578-w

Smith, A. D., & Refsum, H. (2021). Homocysteine – from disease biomarker to disease prevention. Journal of Internal Medicine, 290(4), 826–854. https://doi.org/10.1111/joim.13279

Zhou, L., Liu, J., An, Y., Wang, Y., & Wang, G. (2022). Plasma Homocysteine Level Is Independently Associated With Conventional Atherogenic Lipid Profile and Remnant Cholesterol in Adults. Frontiers in Cardiovascular Medicine, 9(June), 1–11. https://doi.org/10.3389/fcvm.2022.898305

Downloads

Published

2025-09-24

How to Cite

Intan Lambang Astrini, Anak Agung Ayu Eka Cahyani, & Mardiyah Hayati. (2025). Hubungan Kadar Profil Lipid dengan Homosistein pada Pasien Dislipidemia di Laboratorium Klinik Prodia Tangerang. Jurnal Kesehatan Amanah, 9(2), 103–118. https://doi.org/10.57214/jka.v9i2.938